CT:IQ Welcomes emyria to Steering Committee

emyria is focused on data-backed drug development. emyria’s treatments and drug development programs address unmet needs and are unique in that they are informed by Real World Evidence (RWE) they create with patients across their clinical service. Patients are part of the clinical research journey. CT:IQ is thrilled to welcome emyria to the Steering Committee.

PHASTAR joins CT:IQ Steering Committee

We are thrilled to announce that PHASTAR has joined CT:IQ’s Steering Committee. PHASTAR is a specialist biometrics contract research organisation offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. PHASTAR’s priority is ensuring on time, quality work: […]

CT:IQ excited to welcome ARCS to Steering Committee

ARCS Australia Ltd is a national, membership-based organisation focused on the development and growth of the healthcare sector. ARCS provides education, career pathways, professional development and advocacy to the healthcare sector. Membership is made up of individuals working in regulatory affairs, clinical research, health economics, medical information and other disciplines who work in the development […]

CT:IQ welcomes Health Translation Queensland to Steering Committee

We are thrilled to announce that Health Translation Queensland (formally known as Brisbane Diamantina Health Partners) has joined CT:IQ’s Steering Committee. Health Translation Queensland is an NHMRC accredited Research Translation Centre and an innovative partnership that brings together research institutes, universities, and health services to solve some of the nation’s greatest health challenges. By helping […]

Victorian Comprehensive Cancer Centre joins Steering Committee

VCCC alliance The Victorian Comprehensive Cancer Centre (VCCC) alliance is a multi-site, multidisciplinary joint venture partnership between 10 leading medical research, academic and clinical institutions with a shared goal of improving outcomes for Victorian cancer patients. The VCCC alliance partners are Peter MacCallum Cancer Centre, Melbourne Health (including The Royal Melbourne Hospital), the University of […]

CT:IQ welcomes MOCTU, Westmead Hospital to Steering Committee

The Medical Oncology Clinical Trials Unit (MOCTU) at Westmead Hospital has been a pivotal oncology research platform to bring new and pioneering treatment options to the Western Sydney populace. With over 10 years of excellence in oncology research, the unit today offers access to over 70 different types of innovative oncology treatment access through Phase […]

CT:IQ excited to welcome PRAXIS Australia to the Steering Committee

PRAXIS Australia has been helping to strengthen the clinical trials, research and research ethics sectors in Australia since 2015 by offering high quality education and training to individuals and organisations in these sectors. PRAXIS Australia provides training that is cost-effective, accessible and tailorable to increase efficiency, innovation, research quality and outputs. The PRAXIS Australia Board […]

HIIRO Office, QLD Health joins CT:IQ Steering Committee

We are delighted to welcome the Health Innovation, Investment and Research Office (HIIRO) from Queensland Health to the Steering Committee. The Queensland Clinical Trial Coordination Unit (QCTCU) sits within HIIRO in the Office of the Director-General, Queensland Health. QCTCU’s role is to initiate coordination of clinical trial sites and services and is also responsible for […]

CT:IQ welcomes HealthMatch to Steering Committee

HealthMatch is driven by a mission to accelerate medical research allowing for faster and more efficient access to life-changing medication. Through technology that puts the metaphorical steering wheel back in the hands of the patient, our goal is to make the process of finding and accessing clinical trials as simple as possible for all. HealthMatch […]